GENE ONLINE|News &
Opinion
Blog

Feature
Taiwan’s UBI Pharma Experiences Setback with COVID-19 Vaccine Plans
2021-08-18
Booming Bioanalytical CRO Sets Sights on Australian Market with 360biolabs Acquisition
2021-08-17
​​Does Sinovac’s CoronaVac Increase the Risk of Bell’s Palsy After Immunization?
2021-08-17
Vietnam Starts the Country’s First mRNA COVID-19 Human Trial
2021-08-17
Innovent Announces Gastric Cancer Trial Win for Tyvyt, Reveals Plans for Another China Approval
2021-08-16
Can the Gut Microbiome Prevent Age-Related Decline of Brain Function?
2021-08-15
This CRISPR-Based Test Can Detect COVID-19 Variants From Your Spit
2021-08-13
The Defining Role of Metabolism in Human Health and Disease
2021-08-12
GentiBio Bags $157 Million in Series A to Fund Development of Treg Cell Therapies
2021-08-11
Novel Triple Immunotherapy Combo Rekindles Hope for Pancreatic Cancer Patients
2021-08-11
With Increasing Appeal for RNA Technology, Medford Startup Jumps on the SPAC Wagon to Go Public
2021-08-10
New Study Explores How Sleep Deprivation Inhibits Memory Consolidation
2021-08-07
Reversing Obesity: Cytokine Treatment Makes Obese Mice ‘Sweat Fat’, UPenn Study Finds
2021-08-07
A Boom in High-Value M&A and Licensing Deals in the Exosome Field
2021-08-02Partner
Game-Changer in Malaria Prevention: CRISPR-Based Genetic Engineering May Eradicate Malaria Vector Anopheles
2021-08-02
1 32 33 34 35 36 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top